Results 1 - 10 of 10 for CARFILZOMIB
  1. Carfilzomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) ... been treated with at least two other medications. Carfilzomib is in a class of medications called proteasome ...
  2. ... may prevent the growth of tumors . Bortezomib and carfilzomib are proteasome inhibitors used in the treatment of ... therapy. Targeted therapy with proteasome inhibitors ( bortezomib or carfilzomib ). Chemotherapy . A clinical trial of different combinations of ...
  3. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Camptosar (Irinotecan Hydrochloride) Capecitabine CAPOX Carboplatin CARBOPLATIN-TAXOL Carfilzomib Carmubris (Carmustine) Carmustine Carmustine Implant Casodex (Bicalutamide) CeeNU ( ...
  4. ... may prevent the growth of tumors . Bortezomib and carfilzomib are proteasome inhibitors used in the treatment of ... therapy. Targeted therapy with proteasome inhibitors ( bortezomib or carfilzomib ). Chemotherapy . A clinical trial of different combinations of ...
  5. ... lenalidomide (brand name: Revlimid), bortezomib (brand name: Velcade), carfilzomib (brand name: Kyprolis), and pomalidomide (brand name: Pomalyst) ... is more difficult to treat. ● Thalidomide, bortezomib, lenalidomide, carfilzomib, or pomalidomide, given with steroids, and/or standard ...
  6. ... Aredia (Pamidronate Disodium) Becenum (Carmustine) BiCNU (Carmustine) Bortezomib Carfilzomib Carmubris (Carmustine) Carmustine Clafen (Cyclophosphamide) Cyclophosphamide Cytoxan (Cyclophosphamide) ...
  7. Peripheral T-Cell Lymphoma (Lymphoma Research Foundation) - PDF  
    ... Campath) • Alisertib (MLN8237) • Bortezomib (Velcade) • Brentuximab Vedotin (Adcetris) • Carfilzomib (Kyprolis) • Dasatinib (Sprycel) • E7777 • Fludarabine (Fludara) • Lenalidomide (Revlimid) • ...
  8. Multiple Myeloma: Patient Handbook (International Myeloma Foundation) - PDF  
    ... an intensive schedule can be poorly tolerated CRd (carfilzomib/Revlimid/ dexamethasone) • Received NCCN approval as front-line ...
  9. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... R-hyperCVAD) in both untreated and refractory MCL. Carfilzomib (Kyprolis®), which is FDA approved for the treatment ...
  10. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... pembrolizumab (Keytruda®) , nivolumab (Opdivo®) Multiple myeloma: Bortezomib (Velcade®) , carfilzomib (Kyprolis®) , lenaliomide (Revlimid®) , pomalidomide (Pomalyst®) , panobinostat (Farydak®) Myelodysplastic/ ...
Refine by Type